Brand name drug companies are responsible for setting the prices of the prescription drugs in their portfolios. To maximize profits, at the expense of patients, taxpayers and the U.S. health care system, Big Pharma repeatedly hikes prices on existing products and sets increasingly outrageous launch prices on new medications.

Price-gouging, which leads to as many as one-in-three Americans experiencing financial hardship in affording prescription drugs, is enabled by Big Pharma’s egregious anti-competitive practices designed to extend monopolies and block patients from accessing more affordable alternatives, like generics and biosimilars.

Jul 23, 2024

BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS

Big Pharma Giants Top Wall Street Expectations After Hiking Prices on

Jul 15, 2024

CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES

Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate